3 things we've learned about using genAI in coding so far ...

Shares of Replimune Group are rising Monday after the clinical stage biotechnology company shared an important regulatory ...

Replimune stock doubled to $9.00 after FDA accepted its resubmitted application for melanoma drug RP1, with decision expected April 2026.

Solve stubborn bugs faster by breaking things on purpose, questioning your assumptions, and thinking your way to clarity.